Physician profile
Alan Catanzariti
NPI 1023098498
$79,508.48
in general payments reported to CMS, 2019-2025
14 companies · $40K in 2025
The $40K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $12K · 2021: $6,845 · 2022: $6,840 · 2023: $1,268 · 2024: $1,384 · 2025: $40K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $35K · Travel and Lodging: $4,966 · Food and Beverage: $2,033.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $35,320.00 |
| Travel and Lodging | $4,965.86 |
| Food and Beverage | $2,033.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $70,907.77 | 2019-2025 | |
| Wright Medical Technology, INC. | $3,448.34 | 2019-2020 | |
| Mid-Atlantic Surgical Systems, LLC | $2,806.09 | 2019-2025 | |
| Stryker Corporation | $901.17 | 2020-2025 | Prophecy, Invision, Augment Injectable |
| Exactech, INC. | $374.88 | 2025 | |
| Smith+Nephew, INC. | $307.54 | 2024-2025 | Renasys Go V2 Home, Pico |
| Zimmer Biomet Holdings, INC. | $246.67 | 2020 | |
| Medshape, INC. | $137.23 | 2019 | |
| Polynovo North America LLC | $105.95 | 2022 | |
| Orthofix Medical, INC. | $103.70 | 2021 | |
| Kerecis Limited | $98.83 | 2022 | |
| Horizon Therapeutics Plc | $28.57 | 2019 | |
| Integra Lifesciences Corporation | $23.22 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Nextremity Solutions INC. | $18.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Catanzariti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.